What is Gavreto and how does it work?
Gavreto is a prescription medicine used to treat adults with non-small cell lung cancer (NSCLC) that:
- has spread to other parts of the body (metastatic), and
- is caused by abnormal rearranged during transfection (RET) genes. Your healthcare provider will perform a test to make sure that Gavreto is right for you.
It is not known if Gavreto is safe and effective in children.
What are the side effects of Gavreto?
Gavreto may cause serious side effects, including:
- Lung problems. Gavreto may cause severe or life-threatening inflammation of the lungs during treatment, that can lead to death. Tell your healthcare provider right away if you have any new or worsening symptoms, including:
- High blood pressure (hypertension). High blood pressure is common with Gavreto and may sometimes be severe. You should check your blood pressure regularly during treatment with Gavreto. Tell your healthcare provider if you have increased blood pressure readings or get any symptoms of high blood pressure, including:
- Liver problems. Liver problems (increased liver function blood test results) can happen during treatment with Gavreto and may sometimes be serious. Your healthcare provider will do blood tests before and duringtreatment with Gavreto to check you for liver problems. Tell your healthcare provider right away if you get any signs or symptoms of liver problem during treatment, including:
- Bleeding problems.
Gavreto can cause bleeding which can be serious and cause death. Tell your healthcare provider if you have any signs or symptoms of bleeding during treatment, including:
- vomiting blood or if your vomit looks like coffee-grounds
- pink or brown urine
- red or black (looks like tar) stools
- coughing up blood or blood clots
- unusual bleeding or bruising of your skin
- menstrual bleeding that is heavier than normal
- unusual vaginal bleeding
- nose bleeds that happen often
- drowsiness or difficulty being awakened
- change in speech
- Risk of wound healing problems. Wounds may not heal properly during treatment with Gavreto. Tell your healthcare provider if you plan to have any surgery before or during treatment with Gavreto. You should not take Gavreto for at least 5 days before surgery. Your healthcare provider should tell you when you may start taking Gavreto again after surgery.
The most common side effects of Gavreto include:
- muscle and joint painhigh blood pressure
- decreased white blood cell and red blood cell counts
- decreased levels of phosphate in the blood
- decreased levels of body salt (sodium) in the blood
- decreased levels of calcium in the blood
- abnormal liver function blood tests
Gavreto may affect fertility in males and females, which may affect your ability to have children. Talk to your healthcare provider if this is a concern for you.
These are not all of the possible side effects of Gavreto.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is the dosage for Gavreto?
Select patients for treatment with Gavreto based on the presence of a RET gene fusion. Information on FDA-approved tests is available at http://www.fda.gov/CompanionDiagnostics.
The recommended dosage of Gavreto is 400 mg orally once daily on an empty stomach (no food intake for at least 2 hours before and at least 1 hour after taking Gavreto). Continue treatment until disease progression or until unacceptable toxicity.
If a dose of Gavreto is missed, it can be taken as soon as possible on the same day. Resume the regular daily dose schedule for Gavreto the next day.
Do not take an additional dose if vomiting occurs after Gavreto but continue with the next dose as scheduled.
Dosage Modifications For Adverse Reactions
The recommended dose reductions and dosage modifications for adverse reactions are provided in Table 1 and Table 2.
Table 1: Recommended Dose Reductions for Gavreto for Adverse Reactions
|Dose Reduction||Recommended Dosage|
|First||300 mg once daily|
|Second||200 mg once daily|
|Third||100 mg once daily|
Permanently discontinue Gavreto in patients who are unable to tolerate 100 mg taken orally once daily.
The recommended dosage modifications for adverse reactions are provided in Table 2.
Table 2: Recommended Dosage Modifications for Gavreto for Adverse Reactions
|Adverse Reaction||Severity*||Dosage Modification|
|ILD/Pneumonitis||Grade 1 or 2||Withhold Gavreto until resolution. Resume by reducing the dose as shown in Table 1.|
Permanently discontinue Gavreto for recurrent ILD/pneumonitis.
|Grade 3 or 4||Permanently discontinue for confirmed ILD/pneumonitis.|
|Hypertension||Grade 3||Withhold Gavreto for Grade 3 hypertension that persists despite optimal antihypertensive therapy. Resume at a reduced dose when hypertension is controlled.|
|Grade 4||Discontinue Gavreto.|
|Hepatotoxicity||Grade 3 or Grade 4||Withhold Gavreto and monitor AST/ALT once weekly until resolution to Grade 1 or baseline.|
Resume at reduced dose (Table 1).If hepatotoxicity recurs at Grade 3 or higher, discontinue Gavreto.
|Hemorrhagic Events||Grade 3 or Grade 4||Withhold Gavreto until recovery to baseline or Grade 0 or 1.|
Discontinue Gavreto for severe or life-threatening hemorrhagic events.
|Other Adverse Reactions||Grade 3 or 4||Withhold Gavreto until improvement to ≤ Grade 2. Resume at reduced dose (Table 1).|
Permanently discontinue for recurrent Grade 4 adverse reactions.
|* Adverse reactions graded by the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE) version 4.03|
Dose Modification For Use With Combined P-Glycoprotein (P-gp) And Strong CYP3A Inhibitors
Avoid coadministration of Gavreto with known combined P-gp and strong CYP3A inhibitors. If coadministration with a combined P-gp and strong CYP3A inhibitor cannot be avoided, reduce the current dose of Gavreto as recommended in Table 3. After the inhibitor has been discontinued for 3 to 5 elimination half-lives, resume Gavreto at the dose taken prior to initiating the combined P-gp and strong CYP3A inhibitor.
Table 3: Recommended Dosage Modifications for Gavreto for Coadministration with Combined P-gp and Strong CYP3A Inhibitors
|Current Gavreto Dosage||Recommended Gavreto Dosage|
|400 mg orally once daily||200 mg orally once daily|
|300 mg orally once daily||200 mg orally once daily|
|200 mg orally once daily||100 mg orally once daily|
Dose Modification For Use With Strong CYP3A Inducers
Avoid coadministration of Gavreto with strong CYP3A inducers. If coadministration with a strong CYP3A inducer cannot be avoided, increase the starting dose of Gavreto to double the current Gavreto dosage starting on Day 7 of coadministration of Gavreto with the strong CYP3A inducer. After the inducer has been discontinued for at least 14 days, resume Gavreto at the dose taken prior to initiating the strong CYP3A inducer.
What drugs interact with Gavreto?
Effects Of Other Drugs On Gavreto
Strong CYP3A Inhibitors
Avoid coadministration with strong CYP3A inhibitors. Coadministration of Gavreto with a strong CYP3A inhibitor increases pralsetinib exposure, which may increase the incidence and severity of adverse reactions of Gavreto.
Avoid coadministration of Gavreto with combined P-gp and strong CYP3A inhibitors. If coadministration with a combined P-gp and strong CYP3A inhibitor cannot be avoided, reduce the Gavreto dose.
Strong CYP3A Inducers
Coadministration of Gavreto with a strong CYP3A inducer decreases pralsetinib exposure, which may decrease efficacy of Gavreto. Avoid coadministration of Gavreto with strong CYP3A inducers. If coadministration cannot be avoided, increase the Gavreto dose.
Is safe to take Gavreto when pregnant or breastfeeding?
Based on findings from animal studies and its mechanism of action, Gavreto can cause fetal harm when administered to a pregnant woman. There are no available data on Gavreto use in pregnant women to inform drug-associated risk.
There are no data on the presence of pralsetinib or its metabolites in human milk or their effects on either the breastfed child or on milk production. Because of the potential for serious adverse reactions in breastfed children, women should be advised not to breastfeed during treatment with Gavreto and for 1 week after the final dose.
Latest Cancer News
Gavreto is a prescription medicine used to treat adults with non-small cell lung cancer (NSCLC) that has spread to other parts of the body (metastatic), and is caused by abnormal rearranged during transfection (RET) genes.
Multimedia: Slideshows, Images & Quizzes
Top 10 Cancers Quiz
Take this quiz to learn the causes of cancer. Get the facts about the causes, symptoms, and treatments for the world's most...
Lung Cancer Quiz: Signs and Symptoms
Lung cancer is the number one cause of cancer deaths in both men and women in the U.S. and worldwide. Get the facts about lung...
Picture of Lung Cancer
Cancer of the lung, like all cancers, results from an abnormality in the body's basic unit of life, the cell. See a picture of...
Cancer-Fighting Foods in Pictures: Resveratrol, Green Tea, and More
Experts have praised certain foods for their ability to reduce cancer risks. Learn which foods and eating strategies may help...
Signs of Cancer in Men: Could it Be Cancer?
See pictures of which 15 cancer symptoms men ignore such as skin changes, difficulty swallowing, rapid weight loss, a breast...
Signs of Cancer in Women: Symptoms You Can't Ignore
Cancer symptoms can surprise women if they don't know what to watch out for. 15 cancer symptoms women ignore such as weight loss,...
Lung Cancer Symptoms, Stages, Treatment
Learn about lung cancer symptoms and treatments. Get more information on small cell lung cancer, non-small cell lung cancer, and...
Lung Cancer Risks: Myths and Facts
Learn about lung cancer myths and facts. Explore how cigar smoke, menthol, and pollution can increase your risk of lung cancer...
Understanding Cancer: Metastasis, Stages of Cancer, and More
Learn the basics about cancer including types, causes, how it spreads, symptoms and signs, stages and treatment options. Read...
Cancer: Guide to Leukemia
Learn about the common types and stages of leukemia, who gets it, symptoms, tests, treatments, and more. People with blood cancer...
Cancer: How to Lower and Cut Your Risk of Cancer
About a third of all cases of cancer can be prevented. Find out how to lower your chances of getting it.
Cancer: Visual Guide to Thyroid Cancer
Find out the symptoms of thyroid cancer, and learn how to treat it after you get a diagnosis.
Cancer: Cancer 'Remedies' That Don't Work
You may have read about an all-natural cure for cancer. While many therapies are helpful, some aren't worth your time or money....
Cancer: Does This Cause Cancer?
Everything gives you cancer, right? Not really. WebMD's slide show tells you about the research into cancer and cell phones,...
Related Disease Conditions
Second Source article from Government
Cancer Risk Factors
Though it's difficult to say why some people develop cancer while others don't, research shows that certain risk factors increase a person's odds of developing cancer. These risk factors include growing older, family history of cancer, diet, alcohol and tobacco use, and exposure to sunlight, ionizing radiation, certain chemicals, and some viruses and bacteria.
Lung cancer kills more men and women than any other form of cancer. Eight out of 10 lung cancers are due to tobacco smoke. Lung cancers are classified as either small-cell or non-small-cell lung cancers.
Cancer is a disease caused by an abnormal growth of cells, also called malignancy. It is a group of 100 different diseases, and is not contagious. Cancer can be treated through chemotherapy, a treatment of drugs that destroy cancer cells.
Certain behavioral, lifestyle, and environmental factors contribute to cancer. Cancer prevention involves modifying these factors to decrease cancer risk. Tobacco use, alcohol consumption, physical inactivity, inadequate fruit and vegetable intake, and obesity increase the risk of certain cancers. Vaccines, genetic testing, and cancer screening also play a role in cancer prevention.
Cancer pain results from the tumor pressing on nerves or invading bones or organs. Cancer treatments like chemotherapy, radiation, or surgery can also cause pain. Over-the-counter pain relievers, prescription medications, radiation, biofeedback, and relaxation techniques are just some treatments for cancer pain.
Cancer fatigue is a lack of energy that is caused by cancer or cancer treatment, including chemotherapy, radiation, biological therapy, or bone marrow transplantation. Strategies to combat cancer fatigue include scheduling rest, pacing oneself, planning ahead and prioritizing work and activities, eating the right foods, exercising, and practicing proper body mechanics.
Small Cell Lung Cancer vs. Non-Small Cell Lung Cancer
Non-small cell lung cancers (NSCLC) consist of large cell carcinomas, adenocarcinomas, and squamous cell carcinomas. Small cell lung cancer (SCLC) usually starts in the bronchi and typically appears in those who smoke. SCLC and NSCLC are staged in different manners, and SCLC tends to metastasize more quickly than NSCLC. Signs and symptoms of NSCLC and SCLC include shortness of breath, coughing up blood, recurring lung infections, and chest pain. Treatment may involve radiation therapy, chemotherapy, and surgery.
What Are the Four Types of Lung Cancer?
The four types of lung cancer are classified by what kind of cells the cancer affects and what the tumor cells look like under a microscope. Lung cancers can be small-cell or non-small cell, further classified as squamous cell carcinoma or adenocarcinoma.
Which Is the Deadliest Cancer?
Lung cancer is considered to be the most deadly cancer. More people die from lung cancer each year than from breast, colorectal and prostate cancer combined.
Treatment & Diagnosis
- Cancer Research: Going the Distance
- Lung Cancer Q & A
- Cancer and Green Tea
- Cancer Pain Management with Ann Reiner
- Cancer: The Importance of Joining a Cancer Support Group with Selma Schimmel
- Cancer Patients Need Proper Diet and Exercise
- Cancer: Living Well Despite with Win Boerckel
- Cancer Treatment: Writing to Heal with Margie Davis
- Cancer Survival and Attitude with Hamilton Jordan
- Cancer: Childhood Cancer Survivors
- Cancer: Confronting Cancer with Humor
- Cancer: Journaling to Save Your Life
- Cancer: Emotional Aftershocks: When Cancer Comes Back 10/30/02
- Lung Cancer
- Cancer FAQs
- Lung Cancer FAQs
- Dana Reeve Dies of Lung Cancer by Dr. Stoppler
- Cancer,Stroke & Heart Attack Risks- ReducedThrough Walking
- Cancer Care in the Elderly
- Cancer Survivor?
- Sensitive to Smoke, Lung Cancer Gene
- Lung Cancer and Chemotherapy
- Lung Cancer Signs and Symptoms
- 5 Causes of Lung Cancer in Non-Smokers
- What Is the Survival Rate for Lung Cancer Nodules?
- Why Does Lung Cancer Spread So Fast?
- Can You Get Lung Cancer After Quitting Smoking?
- 10 Cancer Symptoms That Men Ignore
- Stage IV Lung Cancer With ALK (Anaplastic Lymphoma Kinase) Rearrangement
- Lung Cancer - Health Beat Audio Segment
- Cancer Prevention: The Anticancer Diet
Medications & Supplements
Health Solutions From Our Sponsors
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.